Giant Cell Arteritis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Reduce to 40 mg after 2 weeks then by 5 mg every 2-4 weeks to 15 mg then by 1-2.5 mg every 2-4 weeks
BSR 2020 GCA guidelines recommend a structured tapering regimen: initial dose (40-60 mg) for 2-4 weeks, then reduce to 40 mg, then reduce by 5 mg every 2-4 weeks to 15 mg, then reduce by 1-2.5 mg every 2-4 weeks thereafter. Total treatment duration is typically 18-24 months minimum. Flares during tapering should prompt a return to the previous effective dose. Tocilizumab can be added as a steroid-sparing agent for relapsing disease.
Reference: BSR 2020 - Guidelines for management of giant cell arteritis